Phase II study of adjuvant chemotherapy with paclitaxel and nedaplatin for FIGO stage IB-IIA uterine cervical cancer with lymph node metastasis following radical hysterectomy: A Kansai Clinical Oncology Group study (KCOG-G1101).

Munetaka Takekuma,Yuka Kasamatsu,Shin Nishio,Hideo Omi,Tsutomu Tabata,Yuji Takei,Kaei Nasu,Yoshiyuki Takahashi,Shinji Toyoda,Yoshikazu Ichikawa,Atsushi Arakawa,Fuminori Ito,Hiroshi Tsubamoto,Taisuke Mori,Kimihiko Ito

Phase II study of adjuvant chemotherapy with paclitaxel and nedaplatin for FIGO stage IB-IIA uterine cervical cancer with lymph node metastasis following radical hysterectomy: A Kansai Clinical Oncology Group study (KCOG-G1101).

2017

Munetaka Takekuma
Yuka Kasamatsu
Shin Nishio
Hideo Omi
Tsutomu Tabata
Yuji Takei
Kaei Nasu
Yoshiyuki Takahashi
Shinji Toyoda
Yoshikazu Ichikawa
Atsushi Arakawa
Fuminori Ito
Hiroshi Tsubamoto
Taisuke Mori
Kimihiko Ito

e17024Background: A multicenter phase II trial was conducted to assess the efficacy and toxicity of paclitaxel and nedaplatin as the initial postoperative adjuvant chemotherapy for high-risk uterin...

Keywords:

Nedaplatin
Oncology
Lymph node
Phases of clinical research
Pathology
Paclitaxel
Cervical cancer
Metastasis
Internal medicine
Radical Hysterectomy
Chemotherapy
Medicine
group study
adjuvant chemotherapy
Toxicity
Clinical Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations